More about

Alzheimer's Disease

News
October 27, 2023
1 min read
Save

Technology use highly accepted by caregivers, those with AD-related agitation

Technology use highly accepted by caregivers, those with AD-related agitation

Technology was found to be both easy to use and highly acceptable in a cohort of those with Alzheimer’s-related agitation and their caregivers, according to a poster presentation at CTAD.

News
October 26, 2023
2 min read
Save

Customized transcription linked to more accurate speech-based AD screening

Customized transcription linked to more accurate speech-based AD screening

A customized speech transcription model logged roughly 30% fewer errors compared with manual or automated methods and may be a more effective tool in assessing verbal Alzheimer’s disease-related impairment.

News
October 26, 2023
2 min read
Save

Computerized training improved cognitive performance in those with MCI

Computerized training improved cognitive performance in those with MCI

Individuals with mild cognitive impairment performed faster on functional skills assessments and logged fewer dropouts when undergoing concurrent burst cognitive training, according to a poster from CTAD.

News
October 25, 2023
2 min read
Save

Participation in digital cognitive test, biomarker assays linked to AD study enrollment

Participation in digital cognitive test, biomarker assays linked to AD study enrollment

Participation in memory-based digital cognitive testing and blood-based biomarker assays for Alzheimer’s-related pathology was linked to successful enrollment into clinical trials for disease-modifying treatment, according to research.

News
October 23, 2023
1 min read
Save

FDA grants orphan drug designation to oral Huntington’s disease therapy

FDA grants orphan drug designation to oral Huntington’s disease therapy

The FDA has granted orphan drug designation to an investigational oral therapeutic for the treatment of Huntington’s disease, according to the manufacturer.

News
October 02, 2023
1 min read
Save

FDA accepts IND with partial clinical hold for oral small molecule Alzheimer’s treatment

FDA accepts IND with partial clinical hold for oral small molecule Alzheimer’s treatment

The FDA has accepted an investigational new drug application for VG-3927, an oral small molecule TREM2 agonist for the potential treatment of Alzheimer’s disease, according to the manufacturer.

News
September 30, 2023
3 min read
Save

Is menopausal hormone therapy linked with dementia risk? Studies offer conflicting views

Is menopausal hormone therapy linked with dementia risk? Studies offer conflicting views

PHILADELPHIA — The short-term effects of postmenopausal hormone therapies on the vascular system and the brain may differ from long-term effects and could be influenced by HT formulation and administration route, according to a speaker.

News
September 25, 2023
1 min read
Save

FDA grants 510(k) clearance for Alzheimer’s, dementia diagnosis software

FDA grants 510(k) clearance for Alzheimer’s, dementia diagnosis software

The FDA has granted 510(k) clearance to German medical technology company AIRAmed for its medical image management and processing system designed to assist physicians in early detection of Alzheimer’s disease and other dementias.

News
September 20, 2023
2 min watch
Save

VIDEO: Clear communication, outreach key to boost inclusivity in clinical research

VIDEO: Clear communication, outreach key to boost inclusivity in clinical research

PHILADELPHIA — In order for underserved communities to successfully engage in clinical research, clear communication and multidisciplinary outreach by the medical community is necessary, according to a speaker.

News
September 19, 2023
2 min read
Save

Patient comfort, knowledge drive philosophy in early diagnosis of neuro conditions

Patient comfort, knowledge drive philosophy in early diagnosis of neuro conditions

PHILADELPHIA — Consideration of multiple factors among patients, families and health care providers drive the process of diagnosing preclinical or prodromal neurologic disease, which should be tailored to the individual, a speaker said.

View more